A triazolothiadiazole inhibitor of c-Met protein kinase

Details for Australian Patent Application No. 2009316756 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Lauffer, David; Li, Pan; Shannon, Dean; Liang, Jianglin

Agent Baldwins

Pub. Number AU-A-2009316756

PCT Pub. Number WO2010/059668

Priority 61/116,033 19.11.08 US

Filing date 18 November 2009

Wipo publication date 27 May 2010

International Classifications

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/433 (2006.01) - Thiadiazoles

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/059668 Priority application(s): WO2010/059668

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009316765-Slatted roller blind

2009316755-Pharmaceutical composition of a potent HCV inhibitor for oral administration